In an article printed in BioPharma Dive, Martin Roessner, Vice President, Biostatistics at Parexel discusses adaptive trial designs, their impact on clinical research, the challenges biopharmaceutical companies face implementing them and how to overcome that, recent FDA guidelines and more.
Other content in this Stream
3 Ways to Reap the Benefits of Adaptive Trials
Learn about common-sense strategies that can help employ adaptive trial designs.
Podcast: Drug Development Innovation Through Adaptive Trials
This PharmaVoice podcast explores adaptive trial designs as a key innovation that, when used, can increase the likelihood of drug launch, particularly in oncology trials.
Parexel Adaptive Trial Design Brochure
Learn how Parexel can help you successfully implement Adaptive Trial Designs.
Modifying Methods as seen in International Clinical Trials
Adaptive Trials Complex but Advantageous Article
Three Keys To Mitigating Risk In Adaptive Trials